Cantor Fitzgerald, L. P. Silence Therapeutics PLC Transaction History
Cantor Fitzgerald, L. P.
- $2.48 Billion
- Q4 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 539,726 shares of SLN stock, worth $1.92 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
539,726
Previous 334,192
61.5%
Holding current value
$1.92 Million
Previous $6.08 Million
38.91%
% of portfolio
0.15%
Previous 0.59%
Shares
12 transactions
Others Institutions Holding SLN
# of Institutions
66Shares Held
24.6MCall Options Held
500Put Options Held
5K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$10.8 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$10.1 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$8.54 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$6.61 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$5.92 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $128M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...